Changes in the Balance of Phosphoinositide 3-kinase/protein Kinase B (Akt) and the Mitogen-activated Protein Kinases (ERK/p38MAPK) Determine a Phenotype of Visceral and Vascular Smooth Muscle Cells

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 1999 May 20

PMID 10330402

Citations 51

Authors

K Hayashi

M Takahashi

K Kimura

W Nishida

H Saga

K Sobue

Affiliations

Soon will be listed here.

Abstract

The molecular mechanisms behind phenotypic modulation of smooth muscle cells (SMCs) remain unclear. In our recent paper, we reported the establishment of novel culture system of gizzard SMCs (Hayashi, K., H. Saga, Y. Chimori, K. Kimura, Y. Yamanaka, and K. Sobue. 1998. J. Biol. Chem. 273: 28860-28867), in which insulin-like growth factor-I (IGF-I) was the most potent for maintaining the differentiated SMC phenotype, and IGF-I triggered the phosphoinositide 3-kinase (PI3-K) and protein kinase B (PKB(Akt)) pathway. Here, we investigated the signaling pathways involved in de-differentiation of gizzard SMCs induced by PDGF-BB, bFGF, and EGF. In contrast to the IGF-I-triggered pathway, PDGF-BB, bFGF, and EGF coordinately activated ERK and p38MAPK pathways. Further, the forced expression of active forms of MEK1 and MKK6, which are the upstream kinases of ERK and p38MAPK, respectively, induced de-differentiation even when SMCs were stimulated with IGF-I. Among three growth factors, PDGF-BB only triggered the PI3-K/PKB(Akt) pathway in addition to the ERK and p38MAPK pathways. When the ERK and p38MAPK pathways were simultaneously blocked by their specific inhibitors or an active form of either PI3-K or PKB(Akt) was transfected, PDGF-BB in turn initiated to maintain the differentiated SMC phenotype. We applied these findings to vascular SMCs, and demonstrated the possibility that the same signaling pathways might be involved in regulating the vascular SMC phenotype. These results suggest that changes in the balance between the PI3-K/PKB(Akt) pathway and the ERK and p38MAPK pathways would determine phenotypes of visceral and vascular SMCs. We further reported that SMCs cotransfected with active forms of MEK1 and MKK6 secreted a nondialyzable, heat-labile protein factor(s) which induced de-differentiation of surrounding normal SMCs.

Citing Articles

Inflammatory Mediators in Atherosclerotic Vascular Remodeling.

Evans B, Yerly A, van der Vorst E, Baumgartner I, Bernhard S, Schindewolf M Front Cardiovasc Med. 2022; 9:868934.

PMID: 35600479 PMC: 9114307. DOI: 10.3389/fcvm.2022.868934.

Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers.

Harryman W, Marr K, Nagle R, Cress A Front Cell Dev Biol. 2022; 10:837585.

PMID: 35300411 PMC: 8921537. DOI: 10.3389/fcell.2022.837585.

Electroacupuncture Attenuated Phenotype Transformation of Vascular Smooth Muscle Cells via PI3K/Akt and MAPK Signaling Pathways in Spontaneous Hypertensive Rats.

Chen X, Yang L, Zheng Y, Li Y, Zhong D, Jin R Chin J Integr Med. 2021; 28(4):357-365.

PMID: 34839455 DOI: 10.1007/s11655-021-2883-y.

Reversal of pulmonary arterial hypertension and neointimal formation by kinin B1 receptor blockade.

Rampa D, Murugesan P, Chao H, Feng H, Dai W, Lee D Respir Res. 2021; 22(1):281.

PMID: 34717626 PMC: 8557528. DOI: 10.1186/s12931-021-01875-w.

Loss of FoxO3a prevents aortic aneurysm formation through maintenance of VSMC homeostasis.

Lu W, Zhou Y, Zeng S, Zhong L, Zhou S, Song H Cell Death Dis. 2021; 12(4):378.

PMID: 33828087 PMC: 8027644. DOI: 10.1038/s41419-021-03659-y.

References

Ray L, Sturgill T . Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. Proc Natl Acad Sci U S A. 1988; 85(11):3753-7. PMC: 280296. DOI: 10.1073/pnas.85.11.3753. View

Shanahan C, Weissberg P, Metcalfe J . Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993; 73(1):193-204. DOI: 10.1161/01.res.73.1.193. View

Kim S, Ip H, Lu M, Clendenin C, Parmacek M . A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol Cell Biol. 1997; 17(4):2266-78. PMC: 232076. DOI: 10.1128/MCB.17.4.2266. View

Cercek B, Fishbein M, Forrester J, Helfant R, Fagin J . Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res. 1990; 66(6):1755-60. DOI: 10.1161/01.res.66.6.1755. View

Shapiro P, EVANS J, Davis R, Posada J . The seven-transmembrane-spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-Jun NH2-terminal kinase groups of mitogen-activated protein kinases. J Biol Chem. 1996; 271(10):5750-4. DOI: 10.1074/jbc.271.10.5750. View

Pyne N, Pyne S . Platelet-derived growth factor activates a mammalian Ste20 coupled mitogen-activated protein kinase in airway smooth muscle. Cell Signal. 1997; 9(3-4):311-7. DOI: 10.1016/s0898-6568(96)00190-8. View

Gimona M, Sparrow M, Strasser P, Herzog M, Small J . Calponin and SM 22 isoforms in avian and mammalian smooth muscle. Absence of phosphorylation in vivo. Eur J Biochem. 1992; 205(3):1067-75. DOI: 10.1111/j.1432-1033.1992.tb16875.x. View

Alessi D, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P . Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996; 15(23):6541-51. PMC: 452479. View

Hu Q, Klippel A, Muslin A, Fantl W, Williams L . Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science. 1995; 268(5207):100-2. DOI: 10.1126/science.7701328. View

10.

Katoh Y, Loukianov E, Kopras E, Zilberman A, Periasamy M . Identification of functional promoter elements in the rabbit smooth muscle myosin heavy chain gene. J Biol Chem. 1994; 269(48):30538-45. View

11.

Alessi D, Cohen P . Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev. 1998; 8(1):55-62. DOI: 10.1016/s0959-437x(98)80062-2. View

12.

Hayashi K, Fujio Y, Kato I, Sobue K . Structural and functional relationships between h- and l-caldesmons. J Biol Chem. 1991; 266(1):355-61. View

13.

Hayashi K, Yano H, Hashida T, Takeuchi R, Takeda O, Asada K . Genomic structure of the human caldesmon gene. Proc Natl Acad Sci U S A. 1992; 89(24):12122-6. PMC: 50710. DOI: 10.1073/pnas.89.24.12122. View

14.

Ueki N, Sobue K, Kanda K, Hada T, Higashino K . Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci U S A. 1987; 84(24):9049-53. PMC: 299689. DOI: 10.1073/pnas.84.24.9049. View

15.

Madsen C, Hershey J, Hautmann M, White S, Owens G . Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem. 1997; 272(10):6332-40. DOI: 10.1074/jbc.272.10.6332. View

16.

Solway J, SELTZER J, Samaha F, Kim S, Alger L, Niu Q . Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem. 1995; 270(22):13460-9. DOI: 10.1074/jbc.270.22.13460. View

17.

Sobue K, Kanda K, Tanaka T, Ueki N . Caldesmon: a common actin-linked regulatory protein in the smooth muscle and nonmuscle contractile system. J Cell Biochem. 1988; 37(3):317-25. DOI: 10.1002/jcb.240370306. View

18.

Campbell G, Ross R . The smooth muscle cell in culture. Physiol Rev. 1979; 59(1):1-61. DOI: 10.1152/physrev.1979.59.1.1. View

19.

Kuro-o M, Nagai R, Tsuchimochi H, Katoh H, Yazaki Y, OHKUBO A . Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem. 1989; 264(31):18272-5. View

20.

Pyles J, March K, Franklin M, Mehdi K, Wilensky R, Adam L . Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res. 1997; 81(6):904-10. DOI: 10.1161/01.res.81.6.904. View